Apteka Exhibition Russian Health Care Week UFI Approved Event
To main
For exhibitors
For visitors

AZ’s China R&D strategy calls for outsourcing


AstraZeneca’s $100 million R&D strategy for China includes a significant focus on outsourcing in Asia. Research chief Steve Yang says AstraZeneca ($AZN) doesn’t want to simply replicate the work it does in the U.S. and Europe. By taking what they know about biomarkers and patient selection, its investigators want to craft a new approach that targets specific disease challenges-such as high rates of gastric and liver cancers-and builds on its tech skills. And to maximize efficiency, the company wants to pursue R&D outsourcing as it forges new research ties with academic groups as well as biotech companies.

Source: fiercepharmamanufacturing.com

Back to the list

Invite partners to the exhibition
Facebook Youtube RSS Feed

Contacts Flashback Site map
119002 Moscow, Arbat str., 35, of. 423
Тel: +7 (495) 925-65-61/62
Fax: +7 (499) 248-07-34